Albioma is an independent energy producer that develops projects in the thermal biomass, solar power, and anaerobic digestion sectors. Co. provides industrial partners with expertise in energy production via hybrid combustion of biomass. In addition, Co. produces biogas by biological decomposition of organic matter in a confined oxygen-free medium, which it either converts into electricity and heat or purifies and then injects into the gas transmission network. It operates facilities on Reunion Island, Mayotte, Guadeloupe, Martinique, and French Guyana, mainland France and Southern Europe. Co. divides its operation into three segments: Thermal Biomass, Solar Power, and Anaerobic Digestion.

GenSight Biologics is a clinical-stage biotechnology company based in France. Co. is engaged in discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system by combining a gene therapy-based approach with its core technology platforms of mitochondrial targeting sequence, or MTS, and optogenetics. Co.'s initial focus has been on developing therapies for severe retinal diseases, with the goal of preserving or restoring vision in patients suffering from sight-threatening ophthalmic diseases. Co.'s product pipeline comprises two candidates for the treatment of sight-threatening retinal degenerative diseases, GSO1O and GSO3O.

PNE Wind is engaged in the development of wind farm projects in several countries in Europe, South Africa and North America. In addition to developing wind farm projects on land (onshore), Co. is also engaged in the development of wind farm projects at sea (offshore). As a project developer, Co. is involved in various stages of the development of a wind farm: from the identification of a site to the realization and operation of the wind power turbines. For offshore wind farms, Co. develops them up to the point where they are ready to construct and then sell them prior to construction. Co. operates in two segments, projecting of wind power turbines and electricity generation.

Rezidor Hotel Group is an international hospitality company managing hotels, brands and assets owned by third parties. Co. operates two main brands, Radisson Blu and Park Inn by Radisson, as well as two more brands, Radisson Red and the Quorvus Collection targeting the luxury segment. All brands are developed and licensed by Co. in Europe, the Middle East and Africa under Master Franchise Agreements with Carlson, a privately held hospitality and travel company. As of Dec 31 2013, Co.'s existing portfolio consisted of 429 hotels with 94,800 rooms in operation and under development in 69 countries across Europe, the Middle East and Africa.